Cas no 1805685-99-7 (4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride)
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride Chemical and Physical Properties
Names and Identifiers
-
- 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride
-
- Inchi: 1S/C8H6Cl2N2O2S/c9-3-5-1-2-6(15(10,13)14)8-7(5)11-4-12-8/h1-2,4H,3H2,(H,11,12)
- InChI Key: HVSOLUZZVXRCDV-UHFFFAOYSA-N
- SMILES: ClS(C1=CC=C(CCl)C2=C1NC=N2)(=O)=O
Computed Properties
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 2
- Complexity: 330
- XLogP3: 1.9
- Topological Polar Surface Area: 71.2
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A061002983-250mg |
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride |
1805685-99-7 | 98% | 250mg |
$882.03 | 2022-04-01 | |
| Alichem | A061002983-500mg |
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride |
1805685-99-7 | 98% | 500mg |
$1,201.19 | 2022-04-01 | |
| Alichem | A061002983-1g |
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride |
1805685-99-7 | 98% | 1g |
$1,985.10 | 2022-04-01 |
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride Related Literature
-
Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disordersJie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
-
Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
-
Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
Additional information on 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride
Introduction to 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride (CAS No. 1805685-99-7)
4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride (CAS No. 1805685-99-7) is a versatile and highly reactive compound that has garnered significant attention in the fields of organic synthesis, medicinal chemistry, and pharmaceutical research. This compound belongs to the class of benzimidazoles, which are known for their broad range of biological activities, including antifungal, antibacterial, and anticancer properties.
The chemical structure of 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride features a benzimidazole core with a chloromethyl group and a sulfonyl chloride functional group. The presence of these functional groups imparts unique reactivity and selectivity to the molecule, making it an invaluable reagent in the synthesis of complex organic molecules and drug candidates.
In recent years, the use of 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride has been explored in various synthetic strategies. One notable application is its role as a building block in the synthesis of benzimidazole derivatives with potential therapeutic applications. For instance, a study published in the Journal of Medicinal Chemistry reported the successful synthesis of a series of benzimidazole-based compounds using this reagent, which exhibited potent antitumor activity against various cancer cell lines.
The chloromethyl group in 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride can undergo nucleophilic substitution reactions, allowing for the introduction of diverse functional groups. This versatility makes it an attractive choice for combinatorial chemistry approaches, where large libraries of compounds can be rapidly synthesized and screened for biological activity. Additionally, the sulfonyl chloride group can react with amines to form sulfonamides, which are important pharmacophores in many drugs.
Beyond its synthetic utility, 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride has also been investigated for its potential as a prodrug precursor. Prodrugs are biologically inactive compounds that are converted into active drugs through metabolic processes in the body. A recent study in the European Journal of Medicinal Chemistry demonstrated that derivatives of this compound could be designed to release active benzimidazole moieties upon activation by specific enzymes, thereby enhancing their therapeutic efficacy and reducing side effects.
The safety and stability of 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride are critical considerations for its practical use in laboratory settings. It is important to handle this compound with care due to its reactivity and potential for forming hazardous byproducts. Proper storage conditions, such as keeping it away from moisture and strong bases, are essential to maintain its integrity and prevent degradation.
In conclusion, 4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride (CAS No. 1805685-99-7) is a powerful and multifaceted reagent with significant potential in organic synthesis and drug discovery. Its unique chemical structure and reactivity profile make it an indispensable tool for researchers aiming to develop novel therapeutic agents and advance our understanding of complex biological systems.
1805685-99-7 (4-Chloromethyl-1H-benzimidazole-7-sulfonyl chloride) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)